Open AccessS2254 Is Vedolizumab the Answer to Decreasing the Incidence of Immune-Mediated Colitis in Patients With Pre-Existing Inflammatory Bowel Disease?
Author(s) -
Majdoline Jayoushe,
Nancy Gupta,
Emanuelle Bellaguarda
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000711064.00932.a9
Subject(s) - medicine , vedolizumab , ipilimumab , inflammatory bowel disease , ulcerative colitis , gastroenterology , colonoscopy , infliximab , colitis , nivolumab , azathioprine , adverse effect , rectum , cancer , colorectal cancer , surgery , immunotherapy , disease